Twist Bioscience Incorporates MOLCURE AI Technology to Augment Therapeutic Antibody Discovery

Twist Bioscience Now Shipping Synthetic RNA Positive Controls for Delta (B.1.617.2) SARS-CoV-2 Variant for Development of Accurate Diagnostic Tests

Twist Bioscience to Report Fiscal 2021 Third Quarter Financial Results on Friday, August 6, 2021

Twist Bioscience Acquires NGS Library Preparation Maker iGenomX

Twist Bioscience Collaborates with Regeneron for Production of Genotyping by Sequencing Panel to Enable Diverse Genome-wide Screening

Twist Bioscience Announces Fireside Chat and Presentation at BIO Digital

DNA Data Storage Alliance Publishes First White Paper, Launches Website

Twist Bioscience Begins Shipping of Synthetic RNA Controls for Kappa (B.1.617.1) SARS-CoV-2 Variants for Development of Accurate Tests

Twist Bioscience Launches Enzymatic Fragmentation Library Preparation Kit for High Uniformity, High-Yield Amplification, Streamlined Next Generation Sequencing Workflow for Targeted Applications

Twist Bioscience to Present at Upcoming Virtual Conferences